Cross-institution positioning
Aug 6, 2026Mixed positioning. No institution has two comparable Schedule 13 observations yet.
Source: Schedule 13 researchMANE Institutional Ownership
Veradermics, Inc
Latest stored close $130.90 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
51/100
2 tracked · 0 comparable
Latest filing
Aug 6, 2026
Positive breadth
2 positive · 0 negative
Recent close
$130.90
Research confidence
Limited
Institutional Research 59/100 · 0 accumulating · 0 reducing / exited
Ownership history
Reported ownership % history
Latest filing Aug 6, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating0
Newly reported2
Reducing / exited
0
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 51/100
Confidence:Limited
Why this signal
- 0 tracked institutions accumulating versus 0 reducing/exited.
- Latest comparable Form 13F activity is net positive across tracked managers.
Conflicting evidence
- Institutions are bullish while recent insider P/S activity leans bearish.
- Institutions are bullish while comparable SEC fundamentals are deteriorating.
Institutional
64/100
Insiders
22/100
Fundamentals
30/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 1, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 15 sales by 7 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Aug 14, 20264 non-amendment material events in the last 90 days; 2 capital-related filing/events; Latest classified evidence: Prospectus filing. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Aug 11, 2026Net income -50.2% YoY; Free cash flow -23.1% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 72% through its reported 52-week range.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Initial Schedule 13G from Fidelity / FMR.
Filed Aug 6, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Aug 6, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Fidelity / FMR
Filed Aug 6, 2026
Direction locked
Citadel Advisors
Filed May 7, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Fidelity / FMR
Filed Aug 6, 2026
Citadel Advisors
Filed May 7, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales157 reporting owner(s)
90-day purchase breadth0
90-day sale breadth7Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Hollander David | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 19.3K | $0.00 | Direct | Sep 3, 2026 |
| Sep 1, 2026 | Hollander David | AGrant, award, or other acquisition | Common Stock | 9.7K | $0.00 | Direct | Sep 3, 2026 |
| Aug 20, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | XSEC transaction code X · derivative | Pre-Funded Warrants | 151.0K | $0.00 | Indirect | Aug 21, 2026 |
| Aug 20, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | XSEC transaction code X · derivative | Pre-Funded Warrants | 149.0K | $0.00 | Indirect | Aug 21, 2026 |
| Aug 20, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | XSEC transaction code X | Common stock, par value $0.00001 per share | 151.0K | — | Indirect | Aug 21, 2026 |
| Aug 20, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | XSEC transaction code X | Common stock, par value $0.00001 per share | 149.0K | — | Indirect | Aug 21, 2026 |
| Aug 19, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | SOpen-market or private sale | Common stock, par value $0.00001 per share | 59.4K | $107.25 | Indirect | Aug 21, 2026 |
| Aug 19, 2026 | MONTANOVA CAPITAL, LLC, Cowen Aaron, Averill Master Fund, Ltd., Averill Madison Master Fund, Ltd. | SOpen-market or private sale | Common stock, par value $0.00001 per share | 690.6K | $107.25 | Indirect | Aug 21, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 3.5K | $0.00 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | SOpen-market or private sale | Common Stock | 249 | $111.28 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | SOpen-market or private sale | Common Stock | 3.0K | $109.38 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | SOpen-market or private sale | Common Stock | 27.5K | $108.45 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | SOpen-market or private sale | Common Stock | 25.2K | $107.53 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | SOpen-market or private sale | Common Stock | 11.5K | $106.72 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Waldman Reid Alexander | MExercise or conversion of derivative | Common Stock | 3.5K | $12.19 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Durso Timothy August | MExercise or conversion of derivative · derivative | Stock Option (Right to Buy) | 3.5K | $0.00 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Durso Timothy August | SOpen-market or private sale | Common Stock | 161 | $111.28 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Durso Timothy August | SOpen-market or private sale | Common Stock | 2.3K | $109.34 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Durso Timothy August | SOpen-market or private sale | Common Stock | 16.8K | $108.38 | Direct | Aug 18, 2026 |
| Aug 17, 2026 | Durso Timothy August | SOpen-market or private sale | Common Stock | 16.3K | $107.52 | Direct | Aug 18, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events0
90-day capital-related2
90-day equity-related0
90-day debt-related0
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | 424B3 | — | Prospectus filing | Capital-related | Filing |
| Aug 11, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 7, 2026 | S-1 | — | Securities registration statement | Capital-related | Filing |
| Jul 15, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| May 12, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 1, 2026 | 8-K | 1.01, 3.02, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Financial statements / exhibits | Equity | Filing |
| Apr 30, 2026 | 424B4 | — | Prospectus filing | Capital-related | Filing |
| Apr 27, 2026 | S-1 | — | Securities registration statement | Capital-related | Filing |
| Apr 27, 2026 | 8-K | 2.02 | Results of operations / financial condition | — | Filing |
| Apr 27, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Mar 30, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Feb 5, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Operating income
$-29.6M
Q2 2026
-83.9% YoY 10-Q filed Aug 11, 2026
Net income
$-23.5M
Q2 2026
-50.2% YoY 10-Q filed Aug 11, 2026
Diluted EPS
$-0.58
Q2 2026
+97.6% YoY 10-Q filed Aug 11, 2026
Operating cash flow
$-35.7M
YTD through Jun 30, 2026
-23.1% YoY 10-Q filed Aug 11, 2026
Free cash flow
$-35.7M
YTD through Jun 30, 2026
-23.1% YoY 10-Q filed Aug 11, 2026
Cash & equivalents
$319.3M
As of Jun 30, 2026
10-Q filed Aug 11, 2026
Assets
$825.7M
As of Jun 30, 2026
10-Q filed Aug 11, 2026
Liabilities
$12.1M
As of Jun 30, 2026
10-Q filed Aug 11, 2026
Stockholders’ equity
$813.6M
As of Jun 30, 2026
+1,169.5% YoY 10-Q filed Aug 11, 2026
Shares outstanding
41.8M
As of Aug 6, 2026
10-Q filed Aug 11, 2026
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$103.89
View live quote ↗
52-week low
$32.00
Feb 4, 2026
52-week high
$131.24
Jul 1, 2026
Below 52-week high
20.8%
1W return
+0.1%
1M return
-7.8%
3M return
+7.9%
6M return
+96.8%
YTD return
1Y return
30-day volatility
47.9%
90-day volatility
67.8%
1Y max drawdown
-24.8%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 4 filing(s) · 1 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Initial Schedule 13G | Initial Schedule 13G | 3.2M | 7.60% | $122.94 | $108.61 | $130.90 |
| Citadel Advisors CIK0001423053 | Apr 30, 2026 observed May 7, 2026 filed · 7d Initial Schedule 13G | Initial Schedule 13G | 1.9M | 4.50% | $99.00 | $107.85 | $130.90 |
| Citadel Advisors CIK0001423053 | Mar 31, 2026 quarter end May 15, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.8M | $130.90 |
Explore more institutional activity
Related research
Compare MANE with other securities showing similar institutional activity or recent accumulation across several tracked institutions.